Loading company…
Trilobio develops automated systems for biological research and laboratory experiments.
Founded in 2021 and based in San Francisco, US, Trilobio develops automated biological research systems. Its high-throughput platform integrates biological processes to reduce manual work in experiments. It serves research institutions, biotechnology firms and educational organizations. In May 2025, Trilobio raised USD 8.000 mn in Seed funding led by Initialized Capital, with participation from Argon Ventures and Lowercarbon Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in